Company Overview and News

0
Lavasa, a billionaire’s dream project, becomes a nightmare for bankers

14h livemint
Mumbai: This onetime hilltop paradise is becoming for some a hell on earth. The days of zero crime are over. Garbage collection is sporadic, so litter soils the man-made lake. Storefronts are vacant. Signs of neglect are everywhere: maintenance is late or non-existent. And that’s for the construction already done. For the unfinished building works—i.e. most of it—there is little happening.
HIN 500185 HCC

0
A billionaire’s folly becomes nightmare for bankers in India

16h malaymail
MUMBAI, June 19 — This onetime hilltop paradise is becoming for some a hell on earth.
HIN 500185 HCC

0
Hindustan Construction wins Rs737 crore contract for Bangladesh nuclear power plant

2018-06-06 livemint
New Delhi:Hindustan Construction Co (HCC) on Wednesday announced that its JV with MAX Group has won a Rs737 crore contract from Russia for a nuclear power plant in Bangladesh.
HIN 500185 HCC

11
Sensex ends over 275 points higher, Nifty near 10,700 after RBI hikes repo rate

2018-06-06 moneycontrol
A three-day losing streak broken and how! Equity benchmarks had a good day of trade, with the Sensex closing 275 points higher, while the Nifty closed near 10,700-mark.
500820 TCHQY HIN ASIANPAINT 532755 CADILAHC CDLYY TECHM 532321 HDB 500180 HDFCBANK 500570 500185 TATAMOTORS HCC TTM

0
HCC bags Rs 737 cr contract for Bangladesh nuclear power plant

2018-06-06 moneycontrol
Hindustan Construction Co (HCC) today announced that its JV with MAX Group has won a Rs 737 crore contract from Russia for a nuclear power plant in Bangladesh. The contract includes civil works of Turbine Island for Unit 1 of Rooppur Nuclear Power Plant (NPP).
HIN 500185 HCC

0
HCC surges 7% on contract win by JV in Bangladesh worth Rs 737 cr

2018-06-06 moneycontrol
Share price of Hindustan Construction Company (HCC) surged 7 percent intraday Wednesday as company won a contract worth Rs 737 crore.
HIN 500185 HCC

0
Lavasa struggles to find new directors

2018-06-06 livemint
Bengaluru: Lavasa Corp. Ltd, which is building India’s first mountain city near Pune, has struggled to find directors for the past few years, forcing the debt-laden company to name junior employees, including a receptionist, to its board.
HIN 500185 HCC

1
32 auditors at listed firms have resigned in last 5 months

2018-06-04 livemint
Mumbai: In the past one month, fifteen auditors have resigned prematurely, besides increasing audit qualifications. The total number of exits, so far, in this calendar year stands at a staggering 32.
EDELWEISS BHUSANSTL 532617 JETAIRWAYS HIN 532922 500185 MANPASAND 500055 HCC 539207

0
Delhi HC asks NHAI to pay remaining 25% of multiple arbitral awards to HCC in 2 weeks

2018-05-03 livemint
New Delhi: The Delhi high court on Thursday directed the National Highway Authority of India (NHAI) to pay the remaining 25% of multiple arbitral awards—amounting more than Rs2,000 crore—to Hindustan Construction Co Ltd (HCC) within two weeks.
HIN 500185 HCC

0
HCC posts biggest intraday percentage loss since 2008

2018-05-03 thehindubusinessline
Auditor of the company’s unit Lavasa Corp says it has “significant doubts about the company’s ability to continue as a going concern”
HIN 500185 HCC

3
High-debt cos’ scrips suffer in Q1 of 2018

2018-04-13 thehindubusinessline
The first quarter of calendar year 2018 has not been too good for Indian investors, with benchmark indices reversing sharply in February.
BAJAJHIND BALRAMCHIN 534690 BHUSANSTL HIN 532712 514034 PNJZY RCOM 532461 LAKSHVILAS JBFIND PNB 500038 500185 500032 500055 HCC

0
HCC#39;s Lavasa to file for bankruptcy?

2018-03-22 moneycontrol
Lavasa Corporation, a subsidiary of Hindustan Construction Company (HCC), in a reply to BSE query, has clarified that the media report about the company filing for bankruptcy is 'misleading' and 'without any basis'.
HIN 500185 HCC

0
HCC sinks 16% despite clarification on report of Lavasa filing for bankruptcy

2018-03-22 moneycontrol
Shares of Hindustan Construction Company fell 15.6 percent intraday on Thursday, despite a clarification from the company on a report that its subsidiary Lavasa Corporation is planning to file for bankruptcy.
HIN 500185 HCC

40
Market Live: Sensex trades lower; SBI, ICICI drag but RIL, HDFC Bank support

2018-03-22 moneycontrol
2:58 pm Land Allotment: Emami Paper Mills said the company has been allotted 4,00,387.05 square meters of land in Sayakha Industrial Estate, District Bharuch, Gujarat, by Gujarat Industrial Development Corporation (GIDC) for greenfield expansion project for manufacturing of paper boards.
AIAENG 500325 GENUSPOWER 532839 532712 DISHTV 530343 532683 RCOM 532121 533208 534816 500570 EICHERMOT RLNIY SBAZ RELEY AXB RELFF HIN AXBA EMAMIPAP 524494 500180 RIFA 500185 AAGGY WABAG 524715 BHRYY RIFS RELIANCE 532215 500390 505200 532187 AXISBANK RIGD INFRATEL HDFCBANK TATAMOTORS HCC ECQRY IPCALAB VDTH INDUSINDBK IBN VTUWY 533269 AXBKY RELINFRA ICICIBANK HDB 532174 SUNPHARMA DENABANK TTM

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to NSE:HCC / HINDUSTAN CONSTRUCTION CO.LTD. on message board site Silicon Investor.

Diamondhead Casino Corporation (DHCC) HCC Insurance Holdings, Inc. (HCC)
SHCC Itu0027s been sleeping! Ready to WAKE UP??? PHCC Priority Healthcare
HCCA IS GOING TO BE THE NEXT BIG WINNER!!! HCCAE
Intensiva Healthcare Corp (IHCC) Beverly Hills Country Club (BHCC)